News

Nayax Earnings Call Scheduled for May 2025: Key Details

Nayax Earnings Call Scheduled for May 2025: Key Details

Nayax Ltd. to Announce Q1 2025 Earnings

Nayax Ltd. (NASDAQ: NYAX), a leading commerce enablement firm, will present their earnings for the first quarter of 2025 on May 13, just before the opening of the U.S. stock markets. This announcement highlights Nayax’s commitment to transparency and its aim to keep investors informed about the company's financial health and operational strategies.

Details of the Earnings Call

The earnings call will be presented in two languages, English and Hebrew. Nayax's CEO, Yair Nechmad, alongside Sagit Manor, the Chief Financial Officer, and Chief Strategy Officer Aaron Greenberg, will discuss the company's performance during the quarter.

English Conference Call Timing

For English-speaking participants, the call is scheduled for 8:30 a.m. Eastern Time, which is 3:30 p.m. Israel Time, and 5:30 a.m. Pacific Time. Emphasizing ease of access, attendees are encouraged to pre-register. Pre-registration allows individuals to receive a unique PIN for immediate access to the call, enhancing the experience by bypassing long wait times.

Hebrew Conference Call Timing

The Hebrew version of the conference call is set for 9:30 a.m. Eastern Time, 4:30 p.m. Israel Time, and 6:30 a.m. Pacific Time. Nayax is making significant efforts to ensure inclusivity for all investors, regardless of their preferred language.

How to Join the Call

To join, participants can pre-register using the provided link, which not only secures a spot but also sends them a confirmation email containing the dial-in numbers and a calendar invite. This pre-registration process is crucial for those keen on joining the conference seamlessly.

Dial-In Information

For those unable to pre-register, Nayax offers convenient dial-in options:
U.S. TOLL-FREE: 1-877-737-7051
ISRAEL TOLL-FREE: 1-809-455-690
INTERNATIONAL: 1-201-689-8878

Accessing the Webcast

Nayax will also provide a live webcast option for investors preferring an online experience. They can access the event via the Nayax Investor Relations website. This dual approach ensures that all stakeholders can engage with the company’s updates in their preferred format.

Post-Call Replay Available

After the call, Nayax will host a replay for those who wish to revisit the discussions. Available until late May, the replay will allow investors who missed the live event to catch up on the latest financial insights and strategic plans of Nayax.

Replay Services

To access the replay, use the following dial-in numbers:
Replay TOLL-FREE: 1-844-512-2921
Replay TOLL/INTERNATIONAL: 1-412-317-6671
Replay TOLL/Israel: 1-809-458-327. Each replay participant will need an access PIN of 13753260 to obtain the recording.

About Nayax

Nayax is committed to transforming the commerce landscape by offering innovative and comprehensive solutions. With a mission to enhance merchant operations and revenue, Nayax specializes in cashless payment acceptance, management suite, and loyalty tools. As of 2025, Nayax operates 11 offices worldwide with a workforce of over 1,100 employees. The company has established connections with more than 80 merchant acquirers, making it an influential player in the global payment facilitator market.

Contact Information

For media inquiries or investor relations, individuals can reach out directly:
Public Relations Contact: Scott Gamm, Strategy Voice Associates, Scott@strategyvoiceassociates.com
Investor Relations: Aaron Greenberg, Chief Strategy Officer, IR@nayax.com

Frequently Asked Questions

What is Nayax planning for their Q1 2025 earnings call?

Nayax intends to release their earnings report on May 13, 2025, and discuss it in a conference call.

Who will be presenting during the earnings call?

Yair Nechmad, CEO, Sagit Manor, CFO, and Aaron Greenberg, Chief Strategy Officer, will present on the call.

How can I join the Nayax conference call?

Participants can join by pre-registering online or using the provided dial-in numbers.

Will there be a replay available after the call?

Yes, Nayax will offer a replay of the call available until May 27, 2025.

Where can I find more information about Nayax?

Visit Nayax's Investor Relations website for detailed insights into the company and its offerings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles